HOLX Hologic Inc

Price (delayed)

$75.85

Market cap

$19.49B

P/E Ratio

17.89

Dividend/share

N/A

EPS

$4.24

Enterprise value

$21.85B

Sector: Healthcare
Industry: Medical Instruments & Supplies

Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn ...

Highlights

The EPS has surged by 126% since the previous quarter
Hologic's net income has surged by 124% QoQ

Key stats

What are the main financial stats of HOLX
Market
Shares outstanding
257.01M
Market cap
$19.49B
Enterprise value
$21.85B
Valuations
Price to earnings (P/E)
17.89
Price to book (P/B)
7.26
Price to sales (P/S)
5.28
EV/EBIT
19.46
EV/EBITDA
14.58
EV/Sales
5.79
Earnings
Revenue
$3.78B
EBIT
$1.12B
EBITDA
$1.5B
Free cash flow
$740.2M
Per share
EPS
$4.24
Free cash flow per share
$2.82
Book value per share
$10.45
Revenue per share
$14.37
TBVPS
$12.3
Balance sheet
Total assets
$7.2B
Total liabilities
$4.49B
Debt
$3.06B
Equity
$2.71B
Working capital
$983M
Liquidity
Debt to equity
1.13
Current ratio
1.79
Quick ratio
1.4
Net debt/EBITDA
1.57
Margins
EBITDA margin
39.7%
Gross margin
59%
Net margin
29.5%
Operating margin
29.3%
Efficiency
Return on assets
16.4%
Return on equity
48%
Return on invested capital
26.8%
Return on capital employed
18.9%
Return on sales
29.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HOLX stock price

How has the Hologic stock price performed over time
Intraday
-0.09%
1 week
-0.33%
1 month
1.58%
1 year
39.84%
YTD
4.15%
QTD
4.15%

Financial performance

How have Hologic's revenue and profit performed over time
Revenue
$3.78B
Gross profit
$2.23B
Operating income
$1.11B
Net income
$1.12B
Gross margin
59%
Net margin
29.5%
Hologic's operating income has surged by 186% QoQ
The operating margin has soared by 150% from the previous quarter
Hologic's net income has surged by 124% QoQ
The company's net margin has surged by 95% QoQ

Growth

What is Hologic's growth rate over time

Valuation

What is Hologic stock price valuation
P/E
17.89
P/B
7.26
P/S
5.28
EV/EBIT
19.46
EV/EBITDA
14.58
EV/Sales
5.79
The EPS has surged by 126% since the previous quarter
The stock's price to earnings (P/E) is 68% less than its last 4 quarters average of 56.7
HOLX's price to book (P/B) is 45% higher than its 5-year quarterly average of 5.0 and 27% higher than its last 4 quarters average of 5.7
HOLX's equity is up by 28% year-on-year and by 20% since the previous quarter
HOLX's price to sales (P/S) is 43% higher than its 5-year quarterly average of 3.7 and 35% higher than its last 4 quarters average of 3.9
The revenue has grown by 15% from the previous quarter and by 12% YoY

Efficiency

How efficient is Hologic business performance
HOLX's return on invested capital has surged by 176% since the previous quarter
The return on sales has surged by 150% since the previous quarter
Hologic's return on assets has surged by 119% QoQ
The ROE has soared by 111% from the previous quarter

Dividends

What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HOLX.

Financial health

How did Hologic financials performed over time
The total assets is 60% higher than the total liabilities
Hologic's quick ratio has increased by 28% QoQ and by 20% YoY
Hologic's current ratio has increased by 22% from the previous quarter and by 7% YoY
The company's debt is 13% higher than its equity
HOLX's equity is up by 28% year-on-year and by 20% since the previous quarter
Hologic's debt to equity has decreased by 23% from the previous quarter and by 22% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.